Clinical Trials Sponsored by Walid HABRE

Total 235 results

Pierre Fabre Medicament

Recruiting

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Melanoma | Non-small Cell Lung Cancer | Solid Tumor, Adult

United States, Australia, France, Spain, Taiwan, Korea, Republic of, China, Netherlands
Pierre Fabre Medicament

Withdrawn

Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma

Hepatic Impairment | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 Mutation

Spain, Czechia, Italy
Pierre Fabre Medicament

Completed

Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors (OCEANI)

Melanoma | BRAF V600E Unresectable or Metastatic Melanoma | BRAF V600E Metastatic NSCLC

China
Pierre Fabre Medicament

Terminated

A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast Cancer (VICTORIA)

Advanced Breast Cancer
Pierre Fabre Medicament

Completed

F17464 in Acute Schizophrenia Trial (FAST)

Schizophrenia

Romania, Russian Federation, Hungary, Latvia, France
Pierre Fabre Medicament

Completed

Efficacy on Volume Reduction and Tolerance of Progressiv' Medical Compressive Therapy (MCT) V0322 BC in Patients With Chronic Venous Oedema

Chronic Venous Insufficiency (CVI)

France
Pierre Fabre Medicament

Completed

Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging

Subject

France
Pierre Fabre Medicament

Completed

PERmixon® in LUTS Evaluation Study (PERLES) (PERLES)

Benign Prostatic Hyperplasia (BPH)

France, Italy, Germany, Spain, Czech Republic
Pierre Fabre Medicament

Completed

Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

Alveolar Osteitis

France, Lithuania, Latvia, Estonia
Pierre Fabre Medicament

Completed

Efficacy and Safety of V0111 Cream on Open Cracked Heel in Diabetic Patients With Polyneuropathy.

Open Cracked Heel in Diabetic Patients With Polyneuropathy

France, Belgium
Pierre Fabre Medicament

Completed

Assessment of V0018 1.5 mg Effect on Craving

Smoking

France
Pierre Fabre Medicament

Completed

Bronchodilator Properties and Safety in Asthma

Asthma

Germany
Pierre Fabre Medicament

Completed

Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

Iron Deficiency Anemia

Romania
Pierre Fabre Medicament

Completed

Exploratory Study in the Relief of Drug-induced Xerostomia Associated With Hyposialia

Drug-induced Xerostomia

Germany
Pierre Fabre Medicament

Completed

A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome

Fibromyalgia Syndrome

Spain, Italy, Portugal, France, Czech Republic, Finland, Germany, Norway, Romania, Sweden, Denmark, Poland, United Kingdom
Pierre Fabre Medicament

Completed

Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

Fibromyalgia Syndrome

Switzerland
Pierre Fabre Medicament

Completed

Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations

Healthy Volunteers

Belgium
Pierre Fabre Medicament

Completed

Oral Vinorelbine as Induction Chemotherapy Followed Concomitant Chemoradiotherapy

Lung Cancer

France
Pierre Fabre Medicament

Withdrawn

Efficacy and Safety Study in Patients Suffering From Knee Osteoarthritis (VESTA)

Knee Osteoarthritis
Pierre Fabre Medicament

Completed

Brain Imaging Study of F17464

Healthy Volunteers

United States
Pierre Fabre Medicament

Completed

Nicotine Patch Safety Study

Smokers

France
Pierre Fabre Medicament

Completed

Acute Sore Throat Pain Study

Acute Sore Throat Pain

United Kingdom, France, Germany
Pierre Fabre Pharma GmbH
iOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Recruiting

BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment (BERING-CRC)

Metastatic Colorectal Carcinoma

Austria, Germany
Pierre Fabre Pharma GmbH
iOMEDICO AG; Pierre Fabre Pharma Austria; Pierre Fabre Pharma AG

Active, not recruiting

Real-life Pan-HER-blockade With Neratinib (ELEANOR)

Breast Neoplasm

Austria, Germany, Switzerland
Walid Shaib, MD
Eli Lilly and Company; Hoosier Cancer Research Network

Active, not recruiting

Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer

Pancreatic Cancer

United States
UNICANCER
Pierre Fabre Medicament

Recruiting

A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer (COBRAF)

Metastatic Colorectal Cancer | BRAF V600E Mutation Positive

France
Groupe Hospitalier du Havre

Not yet recruiting

Transcutaneous Electrical Nerve Stimulation During Exercise in Patients With COPD (proTENS)

Physical Activity | Rehabilitation | COPD | TEN

France
Pierre Fabre Dermo Cosmetique

Completed

Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream

Anti-aging

France
Groupe Hospitalier du Havre

Completed

Slow Expiratory Technique to Improve Alimentation in Children With Bronchiolitis (BRONCHIOL-EAT)

Acute Viral Bronchiolitis

France
Pierre Fabre Dermo Cosmetique

Completed

Assessment of a Cosmetic Product Effect on the Host/Microorganism Relationship in Acneic Subjects

Acne

France
Pierre Fabre Dermo Cosmetique

Terminated

Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD

Dermatitis, Atopic

France
Groupe Hospitalier du Havre

Completed

Transcutaneous Diaphragm Electrical Stimulation in Critically Ill Patients (TESLA)

Critical Illness | Intensive Care Unit | Mechanical Ventilation

France
Groupe Hospitalier du Havre

Completed

Effects of Menthol on Dyspnoea in COPD Patients (MEDiC)

Lung Diseases | Copd | Dyspnea

France
Pierre Fabre Dermo Cosmetique

Completed

Assess the Effects and the Tolerance of Cosmetic Product in the Follow-up Phase of Facial Acne for 1 Year

Acne Vulgaris

France, Italy, Poland
Pierre Fabre Dermo Cosmetique

Completed

Assessment of the Wound Healing Efficacy and Tolerance of a Medical Device on Wounds in Healthy Subjects.

Healthy

Germany
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women

Telogen Effluvium

France
Pierre Fabre Dermo Cosmetique

Completed

Demonstration of the Presence of a Carbonyl Stress in the Hair Follicles of Postpartum Women

Telogen Effluvium

France
Pierre Fabre Dermo Cosmetique

Withdrawn

Identification of Biomarkers and Characterization of Melasma

Chloasma
Groupe Hospitalier du Havre

Completed

Energy Conservation Technique in COPD Patients (UpstAIR)

Chronic Obstructive Pulmonary Disease

France
University of Zurich
Waid City Hospital, Zurich

Completed

Move for Your Mind - Pilot Trial (MFYM - P)

Mild Cognitive Impairment | Mild Dementia | Fall Prevention

Switzerland
Groupe Hospitalier du Havre

Recruiting

Ultrafast Ultrasonographic Oro-laryngeal Measurement in Critically Ill Patients During Weaning From Mechanical Ventilation (REVEAL)

Laryngeal Edema

France
Groupe Hospitalier du Havre

Recruiting

Pulmonary Rehabilitation for COPD Patients: Can Performance Predict Exacerbation? (PREDICT)

Pulmonary Rehabilitation | COPD | COPD Exacerbation

France
Groupe Hospitalier du Havre

Recruiting

Respiratory and Quadriceps Muscle Fatigability After an ICU Acquired Weakness

ICU Acquired Weakness

France
Groupe Hospitalier du Havre

Completed

Ultrasound Measurement of Quadriceps Shortening During Neuromuscular Electrical Stimulation in Critically Ill Patients (DETECT)

ICU Acquired Weakness | Quadriceps Muscle Atrophy

France
Pierre Fabre Medicament
ClinSearch

Withdrawn

Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema (CARING)

Chronic Hand Eczema
Groupe Hospitalier du Havre

Completed

An Intervention to Promote Health Students' Well-being (IFPDays)

Healthy Lifestyle | Students Wellbeing

France
Pierre Fabre Pharma AG

Completed

Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). (Real-CHOICE)

Iron-Deficiency Anemia | Iron-Deficiency

Switzerland
Pfizer
Pierre Fabre Laboratories

Active, not recruiting

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Advanced Solid Tumors | Metastatic Melanoma

United States, Spain, Belgium, Canada, Netherlands
Pierre Fabre Medicament
Clinact

Completed

A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) (CAPSTAN CRC)

Metastatic Colorectal Cancer | BRAF V600E Mutation Positive

France, United Kingdom, Spain, Belgium, Germany, Italy, Austria
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product on Xerosis Induced by Systemic Anticancer Treatments

Xerosis

France

Clinical Trials Sponsored by Walid HABRE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations